A Case Of Intermediate Toxic Epidermal Necrolysis (Lyell Syndrome) Induced By Hydroxychloroquine Sulfate: A Report

Salissou Laouali, Koudoukpo Christiane, Zaki Harouna, Brah M Souleymane, Nouhou Hassan


Malaria is a parasite disease that is endemic in tropical country as Niger (West Africa). Hydroxychloroquine sulfate (HCQ) is a synthetic antimalarial drug that is very often used to treat connective tissue diseases such as, scleroderma, systemic or discoid lupus erythematosus, rheumatoid arthritis. This drug may induce numerous cutaneous adverse reactions as well as the other anti-malarial drugs. We report on a case of intermediate Lyell syndrome that occurred in the first week of treatment of malaria attack with a young woman, aged 19, following the administration of hydroxychloroquine sulfate.

Full Text:


Copyright (c)

European Scientific Journal (ESJ)


ISSN: 1857-7881 (Print)
ISSN: 1857-7431 (Online)


Contact: contact@eujournal.org

To make sure that you can receive messages from us, please add the 'eujournal.org' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.

Publisher: European Scientific Institute, ESI.
ESI cooperates with Universities and Academic Centres on 5 continents.